Shares of Wegovy maker Novo Nordisk slide 7% after earnings miss

  • 📰 CNBC
  • ⏱ Reading Time:
  • 38 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 43%
  • Publisher: 72%

Breaking News: Europe News

Earnings Reports,Earnings Outlook,Health Care Industry

Novo Nordisk on Wednesday announced its second quarter earnings for 2024.

Novo Nordisk on Wednesday said its net profit came in at 20.05 billion Danish kroner in the second quarter of 2024, below forecasts.

Novo Nordisk Wegovy manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 8, 2024. Novo Nordisk on Wednesday posted weaker-than-expected net profit in the second quarter and trimmed its operating profit outlook. EBIT — earnings before interest and tax — came in at 25.93 billion Danish kroner in the second quarter, which was also below the LSEG forecast of 26.86 billion Danish kroner.saying growth was now anticipated to come in between 20% and 28%, rather than the previously expected 22% to 30% range., the Wegovy maker had posted a net profit increase of 28% to 25.4 billion Danish kroner year on year, slightly bumping up its forecasts for sales and operating profit growth.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in İE
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Ireland Ireland Latest News, Ireland Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: CNBC - 🏆 12. / 72 Read more »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: NBCLA - 🏆 319. / 59 Read more »